DLHC:NASDAQDLH Holdings Corp. Analysis
Data as of 2026-06-13 - not real-time
$5.51
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading beneath its short‑term and longer‑term moving averages, underscoring a bearish price pattern. It has found a foothold near a recently identified support level, while the next resistance lies modestly higher. Momentum indicators show a neutral RSI and a MACD that has just turned bullish, hinting at a potential short‑term reversal. Recent price action has been relatively volatile, reflecting heightened trader activity. The beta reading suggests the stock moves less than the broader market, tempering systematic risk. Market sentiment, as captured by the fear‑and‑greed gauge, is in the extreme greed zone, indicating strong investor enthusiasm.
On the fundamentals side, revenue has contracted sharply year‑over‑year, and profit margins remain in the negative territory. Operating cash flow stays positive, providing a modest cushion despite the earnings shortfall. The balance sheet is weighted heavily toward debt, resulting in a leverage profile that is considerably above industry norms. Valuation multiples are well below sector averages, with price‑to‑book and price‑to‑sales ratios indicating a sizable discount to intrinsic estimates. A discounted cash‑flow model points to a fair value substantially higher than the current market price, implying a large upside potential. The company does not pay a dividend, and its exposure is concentrated in U.S. federal contracts, which brings both stability and regulatory sensitivity.
On the fundamentals side, revenue has contracted sharply year‑over‑year, and profit margins remain in the negative territory. Operating cash flow stays positive, providing a modest cushion despite the earnings shortfall. The balance sheet is weighted heavily toward debt, resulting in a leverage profile that is considerably above industry norms. Valuation multiples are well below sector averages, with price‑to‑book and price‑to‑sales ratios indicating a sizable discount to intrinsic estimates. A discounted cash‑flow model points to a fair value substantially higher than the current market price, implying a large upside potential. The company does not pay a dividend, and its exposure is concentrated in U.S. federal contracts, which brings both stability and regulatory sensitivity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near support
- negative earnings and high debt
- bullish MACD signal
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- significant valuation discount
- positive operating cash flow
- upcoming earnings catalyst
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- reliance on federal contracts
- debt burden
- potential upside from DCF valuation
Key Metrics & Analysis
Financial Health
Revenue Growth-33.60%
Profit Margin-1.53%
P/E Ratio-13.4
ROE-4.02%
ROA1.59%
Debt/Equity132.02
P/B Ratio0.7
Op. Cash Flow$19.3M
Free Cash Flow$24.7M
Industry P/E30.6
Technical Analysis
TrendBearish
RSI43.5
Support$5.44
Resistance$5.78
MA 20$5.55
MA 50$5.74
MA 200$5.76
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$12.48
Target Price$10.00
Upside/Downside81.49%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.46
Volatility19.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.